Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
doi: 10.3389/fendo.2022.1043789 Received 14 September 2022 Accepted 21 November 2022 Published 07 December 2022 Volume 13 - 2022 Edited by Luigi Santacroce, University of Bari Aldo Moro, Italy Reviewed by Marialetizia Rastelli, Universit de Lille, France
Nature 505 , 223228 (2014)
The liver, which is the main organ for drug metabolism, is at a particular risk of adverse effects with respect to herbal and nutraceutical agents subject to extensive hepatic biotransformation or induction/inhibition of cytochrome P450 (CYP) enzymes (212)
10.3390/medicina57070733 21 DargenioV.CristoforiF.DargenioC.GiordanoP.IndrioF.CelanoG.et al (2022)
:max_bytes(150000):strip_icc()/rihanna-2-3ce69fcd73294f04bef48285063a764c.jpg)
US$ 22.87
US$ 20.96
US$ 27.54
US$ 22.00
US$ 29.28
US$ 25.51
US$ 25.31
US$ 25.99
US$ 22.84
